Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT06642857
Eligibility Criteria:
Inclusion criteria：
* Patients with gastric or gastroesophageal junction adenocarcinoma confirmed by pathology and with advanced or metastatic disease that cannot be resected
* HER2 negative
* Not received any anti-tumor treatment before.
* After evaluation, the treatment plan is chemotherapy combined with immunotherapy.
* Aged 18 to 75 years old, gender is not limited.
* Expected survival time is greater than or equal to 3 months. Exclusion criteria：
* Patients with malignant tumors other than gastric cancer or those with tumors metastasized to the stomach from other sites.
* Patients who have previously received anti-tumor treatments such as surgery, radiotherapy and chemotherapy, targeted therapy or immunotherapy.
* Patients with severe infections.
* Those with a history of mental illness cannot cooperate with the research.
* Patients with severe heart, liver, kidney and other diseases.
* Pregnant or lactating patients.
* HER2 positive.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06642857
Study Brief:
Protocol Section:
NCT06642857